No going back : Pharma companies’ route to a digitized go-to-market model / [authors, Thomas Solbach ... et al.]
Publication details: [S.l.]: PwC, 2020Description: 13 p.: gráf. ; 1 documento PDFContent type:- texto (visual)
- electrónico
- recurso en línea
| Cover image | Item type | Current library | Home library | Collection | Shelving location | Call number | Materials specified | Vol info | URL | Copy number | Status | Notes | Date due | Barcode | Item holds | Item hold queue priority | Course reserves | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Informes
|
CDO | Colección digital | Acceso libre online | 1000020176316 |
En la cubierta: "As COVID-19 digitizes healthcare, we suggest five steps for pharma companies to transform their market engagement
Digital technologies and interactions are transforming healthcare at an accelerating pace. Until recently, most touchpoints between physicians and pharma companies depended on face-to-face interaction, which often required field forces to drive hundreds of time-consuming kilometers for meetings with doctors.
There are no comments on this title.
Click on an image to view it in the image viewer